[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Nonalcoholic Steatohepatitis (NASH) Market Status and Outlook 2018-2025

August 2018 | 114 pages | ID: G8D0206FEC3EN
99Strategy

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Snapshot

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1: Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2: Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3: Product Segment Overview and Market Status
Part 4: Application / End-User Segment Overview and Market Status
Part 5: Region Segment Overview and Market Status
Part 6: Product & Application Segment Production & Demand by Region
Part 7: Market Forecast by Product, Application & Region
Part 8: Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9: Market Competition and Environment for New Entrants
Part 10: Conclusion

Market Segment as follows:

Key Companies
  • Boehringer Ingelheim
  • Cerenis Therapeutics
  • Connexios Life Sciences
  • Genfit
  • Islet Sciences
  • Nimbus Therapeutics
  • Verva Pharmaceuticals
  • Viking Therapeutics
  • Astazeneca Plc
  • Galmed Pharmaceuticals
  • GENFIT SA
  • Gilead Science
  • Novo Nordisk
  • Immuron
  • Intercepts Pharmaceuticals
  • Enzo Biochem
  • Tobira Therapeutics
Market by Type
  • Weight Loss Treatment
  • Insulin-Sensitizing Agents
  • Lipid-Lowering Drugs
  • Antioxidants
  • Other
Market by Application
  • Hospitals
  • Clinics
  • Research Institute
  • Other
PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Nonalcoholic Steatohepatitis (NASH) Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Weight Loss Treatment
  3.1.2 Insulin-Sensitizing Agents
  3.1.3 Lipid-Lowering Drugs
  3.1.4 Antioxidants
  3.1.5 Other
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospitals
  4.1.2 Clinics
  4.1.3 Research Institute
  4.1.4 Other
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Weight Loss Treatment Production by Region
    6.1.1.2 Insulin-Sensitizing Agents Production by Region
    6.1.1.3 Lipid-Lowering Drugs Production by Region
    6.1.1.4 Antioxidants Production by Region
    6.1.1.5 Other Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospitals Production by Region
    6.1.2.2 Clinics Production by Region
    6.1.2.3 Research Institute Production by Region
    6.1.2.4 Other Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Weight Loss Treatment Demand by Region
    6.2.1.2 Insulin-Sensitizing Agents Demand by Region
    6.2.1.3 Lipid-Lowering Drugs Demand by Region
    6.2.1.4 Antioxidants Demand by Region
    6.2.1.5 Other Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospitals Demand by Region
    6.2.2.2 Clinics Demand by Region
    6.2.2.3 Research Institute Demand by Region
    6.2.2.4 Other Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Boehringer Ingelheim
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Cerenis Therapeutics
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Connexios Life Sciences
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Genfit
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Islet Sciences
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Nimbus Therapeutics
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Verva Pharmaceuticals
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Viking Therapeutics
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Astazeneca Plc
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Galmed Pharmaceuticals
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 GENFIT SA
8.12 Gilead Science
8.13 Novo Nordisk
8.14 Immuron
8.15 Intercepts Pharmaceuticals
8.16 Enzo Biochem
8.17 Tobira Therapeutics

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

LIST OF TABLES

Table Nonalcoholic Steatohepatitis (NASH) Industry Dynamics & Regulations List
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Revenue, Cost and Margin, 2015-2018E
Table Global Nonalcoholic Steatohepatitis (NASH) Market Status by Type 2015-2018E, in USD Million
Table Global Nonalcoholic Steatohepatitis (NASH) Market Status by Application 2015-2018E, in USD Million
Table Global Nonalcoholic Steatohepatitis (NASH) Market Status by Application 2015-2018E, in Volume
Table Global Nonalcoholic Steatohepatitis (NASH) Market by Region 2015-2018E, in USD Million
Table Global Nonalcoholic Steatohepatitis (NASH) Market Share by Region in 2018, in USD Million
Table Global Nonalcoholic Steatohepatitis (NASH) Market by Region 2015-2018E, in Volume
Table Global Nonalcoholic Steatohepatitis (NASH) Market Share by Region in 2018, in Volume
Table Weight Loss Treatment Production Value by Region 2015-2018E, in USD Million
Table Weight Loss Treatment Production Volume by Region 2015-2018E, in Volume
Table Insulin-Sensitizing Agents Production Value by Region 2015-2018E, in USD Million
Table Insulin-Sensitizing Agents Production Volume by Region 2015-2018E, in Volume
Table Lipid-Lowering Drugs Production Value by Region 2015-2018E, in USD Million
Table Lipid-Lowering Drugs Production Volume by Region 2015-2018E, in Volume
Table Antioxidants Production Value by Region 2015-2018E, in USD Million
Table Antioxidants Production Volume by Region 2015-2018E, in Volume
Table Other Production Value by Region 2015-2018E, in USD Million
Table Other Production Volume by Region 2015-2018E, in Volume
Table Hospitals Production Value by Region 2015-2018E, in USD Million
Table Hospitals Production Volume by Region 2015-2018E, in Volume
Table Clinics Production Value by Region 2015-2018E, in USD Million
Table Clinics Production Volume by Region 2015-2018E, in Volume
Table Research Institute Production Value by Region 2015-2018E, in USD Million
Table Research Institute Production Volume by Region 2015-2018E, in Volume
Table Other Production Value by Region 2015-2018E, in USD Million
Table Other Production Volume by Region 2015-2018E, in Volume
Table Weight Loss Treatment Market Size by Region 2015-2018E, in USD Million
Table Weight Loss Treatment Market Size by Region 2015-2018E, in Volume
Table Insulin-Sensitizing Agents Market Size by Region 2015-2018E, in USD Million
Table Insulin-Sensitizing Agents Market Size by Region 2015-2018E, in Volume
Table Lipid-Lowering Drugs Market Size by Region 2015-2018E, in USD Million
Table Lipid-Lowering Drugs Market Size by Region 2015-2018E, in Volume
Table Antioxidants Market Size by Region 2015-2018E, in USD Million
Table Antioxidants Market Size by Region 2015-2018E, in Volume
Table Other Market Size by Region 2015-2018E, in USD Million
Table Other Market Size by Region 2015-2018E, in Volume
Table Hospitals Market Size by Region 2015-2018E, in USD Million
Table Hospitals Market Size by Region 2015-2018E, in Volume
Table Clinics Market Size by Region 2015-2018E, in USD Million
Table Clinics Market Size by Region 2015-2018E, in Volume
Table Research Institute Market Size by Region 2015-2018E, in USD Million
Table Research Institute Market Size by Region 2015-2018E, in Volume
Table Other Market Size by Region 2015-2018E, in USD Million
Table Other Market Size by Region 2015-2018E, in Volume
Table GlobalNonalcoholic Steatohepatitis (NASH) Forecast by Type 2019F-2025F, in USD Million
Table Nonalcoholic Steatohepatitis (NASH) Forecast by Type 2019F-2025F, in Volume
Table Nonalcoholic Steatohepatitis (NASH) Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Nonalcoholic Steatohepatitis (NASH) Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Nonalcoholic Steatohepatitis (NASH) Market Forecast by Region 2019F-2025F, in USD Million
Table Nonalcoholic Steatohepatitis (NASH) Market Forecast by Region 2019F-2025F, in Volume
Table Boehringer Ingelheim Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of Boehringer Ingelheim
Table Cerenis Therapeutics Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of Cerenis Therapeutics
Table Connexios Life Sciences Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of Connexios Life Sciences
Table Genfit Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of Genfit
Table Islet Sciences Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of Islet Sciences
Table Nimbus Therapeutics Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of Nimbus Therapeutics
Table Verva Pharmaceuticals Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of Verva Pharmaceuticals
Table Viking Therapeutics Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of Viking Therapeutics
Table Astazeneca Plc Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of Astazeneca Plc
Table Galmed Pharmaceuticals Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of Galmed Pharmaceuticals
Table GENFIT SA Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of GENFIT SA
Table Gilead Science Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of Gilead Science
Table Novo Nordisk Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of Novo Nordisk
Table Immuron Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of Immuron
Table Intercepts Pharmaceuticals Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of Intercepts Pharmaceuticals
Table Enzo Biochem Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of Enzo Biochem
Table Tobira Therapeutics Information
Table Nonalcoholic Steatohepatitis (NASH) Sales, Cost, Margin of Tobira Therapeutics
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Revenue by Company 2015-2017, in USD Million
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Volume by Company 2015-2017, in Volume
Table Global Nonalcoholic Steatohepatitis (NASH) Sales Volume by Company in 2018, in Volume

LIST OF FIGURES

Figure Nonalcoholic Steatohepatitis (NASH) Picture
Figure Nonalcoholic Steatohepatitis (NASH) Industry Chain Diagram
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Revenue 2015-2018E, in USD Million
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Volume 2015-2018E, in Volume
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Status by Type 2015-2018E, in Volume
Figure North America Nonalcoholic Steatohepatitis (NASH) Market Size and Growth 2015-2018E, in USD Million
Figure North America Nonalcoholic Steatohepatitis (NASH) Market Size and Growth 2015-2018E, in Volume
Figure Europe Nonalcoholic Steatohepatitis (NASH) Market Size and Growth 2015-2018E, in USD Million
Figure Europe Nonalcoholic Steatohepatitis (NASH) Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Nonalcoholic Steatohepatitis (NASH) Market Size and Growth 2015-2018E, in Volume
Figure South America Nonalcoholic Steatohepatitis (NASH) Market Size and Growth 2015-2018E, in USD Million
Figure South America Nonalcoholic Steatohepatitis (NASH) Market Size and Growth 2015-2018E, in Volume
Figure Middle East Nonalcoholic Steatohepatitis (NASH) Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Nonalcoholic Steatohepatitis (NASH) Market Size and Growth 2015-2018E, in Volume
Figure Africa Nonalcoholic Steatohepatitis (NASH) Market Size and Growth 2015-2018E, in USD Million
Figure Africa Nonalcoholic Steatohepatitis (NASH) Market Size and Growth 2015-2018E, in Volume
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Price Forecast 2019F-2025F
Figure Global Nonalcoholic Steatohepatitis (NASH) Gross Margin Forecast 2019F-2025F
Figure Global Nonalcoholic Steatohepatitis (NASH) Sales Revenue by Company in 2018, in USD Million
Figure Global Nonalcoholic Steatohepatitis (NASH) Price by Company in 2018
Figure Global Nonalcoholic Steatohepatitis (NASH) Gross Margin by Company in 2018

More Publications

Need Help?

Ask a Question

Market Reports

All Categories